Company News

FTC Takes Action on Deceptive CBD Product Claims

Seller of gummies and topical ointments agrees to not make unsupported claims and will pay $30K in consumer redress.

Author Image

By: Christine Esposito

Editor-in-Chief

The Federal Trade Commission (FTC) today announced its latest law enforcement action to halt what it calls deceptive health and efficacy claims in the growing market for cannabidiol (CBD) products. In the action—the first since the Commission announced a crackdown on such false claims last December—Scottsdale, AZ-based Kushly Industries LLC (Kushly) and the company’s sole officer Cody Alt have agreed not to make false or unsupported claims or falsely claim that scientific evidence exists to back...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters